129 related articles for article (PubMed ID: 3925022)
1. An enzyme-linked immunosorbent assay for autoantibodies against the nuclear protein Scl-70.
Geisler C; Høier-Madsen M
J Immunol Methods; 1985 Jun; 80(2):211-9. PubMed ID: 3925022
[TBL] [Abstract][Full Text] [Related]
2. A rapid screening enzyme linked immunosorbent assay for autoantibodies to extractable nuclear antigens.
Warlow R; Carrano J; Dawkins R
Diagn Immunol; 1984; 2(3):154-60. PubMed ID: 6437732
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to topoisomerase I (Scl-70): analysis by gel diffusion, immunoblot, and enzyme-linked immunosorbent assay.
Hildebrandt S; Weiner ES; Senecal JL; Noell GS; Earnshaw WC; Rothfield NF
Clin Immunol Immunopathol; 1990 Dec; 57(3):399-410. PubMed ID: 2173985
[TBL] [Abstract][Full Text] [Related]
4. Performance of a multiplex assay compared to enzyme and precipitation methods for anti-ENA testing in systemic lupus and systemic sclerosis.
Albon S; Bunn C; Swana G; Karim Y
J Immunol Methods; 2011 Feb; 365(1-2):126-31. PubMed ID: 21184759
[TBL] [Abstract][Full Text] [Related]
5. Specificity of anti-Sm antibodies by ELISA for systemic lupus erythematosus: increased sensitivity of detection using purified peptide antigens.
Field M; Williams DG; Charles P; Maini RN
Ann Rheum Dis; 1988 Oct; 47(10):820-5. PubMed ID: 3143318
[TBL] [Abstract][Full Text] [Related]
6. Scl-86, a marker antigen for diffuse scleroderma.
van Venrooij WJ; Stapel SO; Houben H; Habets WJ; Kallenberg CG; Penner E; van de Putte LB
J Clin Invest; 1985 Mar; 75(3):1053-60. PubMed ID: 3980727
[TBL] [Abstract][Full Text] [Related]
7. An improved incubation apparatus for Western blots used for the detection of antinuclear antibodies.
Westgeest AA; Bons JC; Van den Brink HG; Aarden LA; Smeenk RJ
J Immunol Methods; 1986 Dec; 95(2):283-8. PubMed ID: 3794348
[TBL] [Abstract][Full Text] [Related]
8. Are ACA and Scl 70 antibodies mutually exclusive?
Jarzabek-Chorzelska M; Błaszczyk M; Kołacińska-Strasz Z; Jabłonska S; Chorzelski T; Maul GG
Br J Dermatol; 1990 Feb; 122(2):201-8. PubMed ID: 2107867
[TBL] [Abstract][Full Text] [Related]
9. The use of ELISA for the measurement of autoantibodies to nuclear antigens: comparison with other methodologies.
Firer MA; Shoenfeld Y; Isenberg DA; Slor H
Isr J Med Sci; 1988 Dec; 24(12):747-50. PubMed ID: 3147270
[No Abstract] [Full Text] [Related]
10. Immunolocalization and partial characterization of a nucleolar autoantigen (PM-Scl) associated with polymyositis/scleroderma overlap syndromes.
Reimer G; Scheer U; Peters JM; Tan EM
J Immunol; 1986 Dec; 137(12):3802-8. PubMed ID: 3537125
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies to nucleolar antigens in systemic scleroderma: clinical correlations.
Błaszczyk M; Jarzabek-Chorzelska M; Jabłońska S; Chorzelski T; Kołacińska-Strasz Z; Beutner EH; Kumar V
Br J Dermatol; 1990 Oct; 123(4):421-30. PubMed ID: 2128868
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of patients with antibodies directed against proliferating cell nuclear antigen.
Fritzler MJ; McCarty GA; Ryan JP; Kinsella TD
Arthritis Rheum; 1983 Feb; 26(2):140-5. PubMed ID: 6600614
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a novel line-blot immunoassay for the detection of antibodies to extractable nuclear antigens.
Damoiseaux J; Boesten K; Giesen J; Austen J; Tervaert JW
Ann N Y Acad Sci; 2005 Jun; 1050():340-7. PubMed ID: 16014550
[TBL] [Abstract][Full Text] [Related]
14. Serological markers in progressive systemic sclerosis: clinical correlations.
Catoggio LJ; Bernstein RM; Black CM; Hughes GR; Maddison PJ
Ann Rheum Dis; 1983 Feb; 42(1):23-7. PubMed ID: 6402991
[TBL] [Abstract][Full Text] [Related]
15. Subsets of autoantibodies to extractable nuclear antigens (ENA) as assayed by ELISA correlate with specific clinical abnormalities in SLE.
Warlow RS
Scand J Rheumatol; 1986; 15(1):57-67. PubMed ID: 2421399
[TBL] [Abstract][Full Text] [Related]
16. Purification of the Sm nuclear autoantigen. Detection and clinical significance of IgM antibody.
Pollard KM; Tan EM
Clin Exp Immunol; 1985 Jun; 60(3):586-96. PubMed ID: 4017287
[TBL] [Abstract][Full Text] [Related]
17. Circulating Fc gamma receptor-specific autoantibodies in localized and systemic scleroderma.
Davis K; Boros P; Keltz M; Unkeless JC; Fleischmajer R
J Am Acad Dermatol; 1995 Oct; 33(4):612-6. PubMed ID: 7673494
[TBL] [Abstract][Full Text] [Related]
18. Specificity of anti-Scl-70 antibodies in scleroderma: increased sensitivity of detection using purified DNA topoisomerase I from calf thymus.
Tsay GJ; Fann RH; Hwang J
J Rheumatol; 1990 Oct; 17(10):1314-9. PubMed ID: 2174971
[TBL] [Abstract][Full Text] [Related]
19. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
Levo Y; Lotan C
Isr J Med Sci; 1982 Feb; 18(2):287-9. PubMed ID: 6978327
[No Abstract] [Full Text] [Related]
20. Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights.
Mahler M; Raijmakers R
Autoimmun Rev; 2007 Aug; 6(7):432-7. PubMed ID: 17643929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
